ResearcherUniversitätsmedizin RostockNo recent work listed
Olaf Wolkenhauer A
Matched on ORCID iD 0000-0001-6105-2937; OpenAlex author ID A5022724143. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2011: 1 paper · 2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper
Papers 5
- Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. Co-author DOI 10.1016/j.hbpd.2022.12.003↗
- Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidity and ageing/cellular senescence (SASKi… Co-author DOI 10.1136/bmjopen-2020-039560↗
- Mathematical modelling unravels regulatory mechanisms of interferon-γ-induced STAT1 serine-phosphorylation and MUC4 expression in pancreatic cancer cells. Co-author DOI 10.1049/iet-syb.2011.0017↗
- Parameter identifiability and sensitivity analysis predict targets for enhancement of STAT1 activity in pancreatic cancer and stellate cells. Last author DOI 10.1371/journal.pcbi.1002815↗
- Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach. Co-author DOI 10.1186/1476-4598-10-13↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Robert Jaster · 5 shared papers, 2011–2023 · strength 0.35
- Paper Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. DOI 10.1016/j.hbpd.2022.12.003↗
- Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗
- Paper Mathematical modelling unravels regulatory mechanisms of interferon-γ-induced STAT1 serine-phosphorylation and MUC4 exp… DOI 10.1049/iet-syb.2011.0017↗
- Georg Fuellen · 2 shared papers, 2020–2023 · strength 0.24
- Paper Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. DOI 10.1016/j.hbpd.2022.12.003↗
- Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗
- Hugo Murua Escobar · 2 shared papers, 2020–2023 · strength 0.24
- Paper Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. DOI 10.1016/j.hbpd.2022.12.003↗
- Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗
- Falko Lange · 3 shared papers, 2011–2020 · strength 0.16
- Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗
- Paper Parameter identifiability and sensitivity analysis predict targets for enhancement of STAT1 activity in pancreatic canc… DOI 10.1371/journal.pcbi.1002815↗
- Paper Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach. DOI 10.1186/1476-4598-10-13↗
- Dietmar Zechner · 1 shared paper, 2023 · strength 0.15
- Denis Revskij · 1 shared paper, 2023 · strength 0.15
- Katja Rateitschak · 3 shared papers, 2011–2012 · strength 0.11
- Paper Mathematical modelling unravels regulatory mechanisms of interferon-γ-induced STAT1 serine-phosphorylation and MUC4 exp… DOI 10.1049/iet-syb.2011.0017↗
- Paper Parameter identifiability and sensitivity analysis predict targets for enhancement of STAT1 activity in pancreatic canc… DOI 10.1371/journal.pcbi.1002815↗
- Paper Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach. DOI 10.1186/1476-4598-10-13↗
- Larissa Henze · 1 shared paper, 2020 · strength 0.09
- Daniel H. Palmer · 1 shared paper, 2020 · strength 0.09
- Christina Kossow · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.